DelfaGLP-1 Atlas

← Trials/Trial dossier/NCT06500143

RESIDUAL

Completed

Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery

The RESIDUAL Study : Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery: a Cross-sectional Study

Assets

Dulaglutide / Semaglutide

Listed sites

1

Recruiting sites

—

Enrollment

94

actual

Study population

Perioperative / gastric aspiration risk

Key I/E criterion

—

Primary endpoint

•Increased residual gastric content

Footprint

Where this trial recruits

Site locations as reported to ClinicalTrials.gov. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT06500143
Org study IDMP-12-2025-3794

Timeline

Milestones

Study first posted2024-07-15actual
Study start2024-10-09actual
Primary completion2025-02-28actual
Study completion2025-02-28actual
Last update posted2026-01-16actual

Assets

Investigational agents

DulaglutideSemaglutide

Study populations

Who this study enrolls

Perioperative / gastric aspiration risk

Eligibility

Who can enroll

Minimum age18 Years
SexAll
Healthy volunteersAccepted
Sampling methodNon probability sample

Study population text

Adult population undergoing elective surgery

Inclusion criteria

•American Society of Anesthesiologists (ASA) class 1-4 patients
•Age ≥ 18 years old
•Fasted state (2 hours for clear liquids, 6 hours for solids)
•Elective surgery
•Last dose of once-weekly semaglutide or dulaglutide 7 days or more before surgery (for GLP-1RA group)

Exclusion criteria

•Last dose of GLP-1RA less than 7 days before surgery
•Inability to lay on the right-side for ultrasound
•Pregnancy
•History of gastric surgery or large hiatal hernia

Endpoints (1)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Other clinical outcomes

1 endpoint
Primary/protocol endpoint

Increased residual gastric content

Time frame:Preoperative (day of surgery)

categorical status, event

Publications (10)

Bibliography

Records linked to this trial through ClinicalTrials.gov references, PubMed NCT search, and curated study seeds. 'Canonical' marks design/result papers; others are registry references or candidates.

Registry references + supporting bibliography

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2
Snapshot dateJuly 1, 2026
Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)
Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 1, 2026 snapshot.